Dravet Syndrome
Showing 26 - 48 of 48
Cannabidiol (CBD) and Its Effects in Severe Epilepsy
Withdrawn
- Dravet Syndrome
- Lennox Gastaut Syndrome
- (no location specified)
Dec 2, 2021
Study of Rare Epileptic Syndromes in Children and Adolescents
Not yet recruiting
- Epilepsy
- +2 more
-
Paris, FranceHopital Robert Debré - Neurologie
Nov 8, 2021
Dravet Syndrome, Lennox Gastaut Syndrome Trial in Seoul (Cannabidiol)
Unknown status
- Dravet Syndrome
- Lennox Gastaut Syndrome
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University College of Medicine
Oct 26, 2020
Dravet Syndrome Trial in Fair Lawn (EPX-100 (Clemizole Hydrochloride), Placebos)
Completed
- Dravet Syndrome
- EPX-100 (Clemizole Hydrochloride)
- Placebos
-
Fair Lawn, New JerseyTKL Research
Jun 23, 2020
Dravet Syndrome Trial in Los Angeles (Fenfluramine)
Available
- Dravet Syndrome
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Jun 16, 2020
Dravet Syndrome, Epileptic Encephalopathies Associated With SCN1A Mutations Trial in Fort Worth (Stiripentol)
No longer available
- Dravet Syndrome
- Epileptic Encephalopathies Associated With SCN1A Mutations
-
Fort Worth, TexasCook Children's Medical Center
Jan 31, 2020
Dravet Syndrome, Seizure Disorder Trial in Canada, United States (ZX008 (Fenfluramine Hydrochloride), Matching Placebo)
Unknown status
- Dravet Syndrome
- Seizure Disorder
- ZX008 (Fenfluramine Hydrochloride)
- Matching Placebo
-
Phoenix, Arizona
- +20 more
Jan 4, 2020
Dravet Syndrome Trial in Worldwide (ZX008 - 0.8 mg/kg/day, ZX008 - 0.2 mg/kg/day, Placebo)
Unknown status
- Dravet Syndrome
- ZX008 - 0.8 mg/kg/day
- +2 more
-
Melbourne, Australia
- +33 more
Jan 2, 2020
Dravet Syndrome Trial in Aurora (Stiripentol)
No longer available
- Dravet Syndrome
-
Aurora, ColoradoChildren's Hospital Colorado
Oct 2, 2019
Epilepsy, Dravet Syndrome Trial in Worldwide (GWP42003-P, Placebo Control)
Completed
- Epilepsy
- Dravet Syndrome
- GWP42003-P
- Placebo Control
-
Birmingham, Alabama
- +37 more
Jul 11, 2019
Dravet Syndrome Trial in Cincinnati (Stiripentol)
Approved for marketing
- Dravet Syndrome
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 9, 2019
Dravet Syndrome Trial in San Francisco (ZX008 (Fenfluramine Hydrochloride))
Unknown status
- Dravet Syndrome
- ZX008 (Fenfluramine Hydrochloride)
-
San Francisco, CaliforniaUniversity of California San Francisco
Jun 11, 2019
Epilepsy, Dravet Syndrome Trial in Worldwide (GWP42003-P 20 mg/kg/day Dose, Placebo control)
Completed
- Epilepsy
- Dravet Syndrome
- GWP42003-P 20 mg/kg/day Dose
- Placebo control
-
Miami, Florida
- +21 more
Jul 26, 2018
Epilepsy, Dravet Syndrome Trial in United Kingdom, United States (GWP42003-P 5 mg/kg/day Dose, Placebo control, GWP42003-P 10
Completed
- Epilepsy
- Dravet Syndrome
- GWP42003-P 5 mg/kg/day Dose
- +3 more
-
Miami, Florida
- +10 more
Jul 26, 2018
Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome Trial in New York (Turmeric)
Withdrawn
- Epilepsy
- +4 more
- Turmeric
-
New York, New YorkNew York University School of Medicine
Apr 26, 2018
Dravet Syndrome Trial (Cannabidiol Oral Solution, Placebo Solution)
Withdrawn
- Dravet Syndrome
- Cannabidiol Oral Solution
- Placebo Solution
- (no location specified)
Jan 2, 2018
Charlotte's Web Responders Versus Non- Responders inDravet
Completed
- Dravet Syndrome
-
Denver, ColoradoDenver Health Medical Center
Dec 13, 2017
Dravet Syndrome Trial in Rochester (stiripentol)
No longer available
- Dravet Syndrome
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 26, 2013